No myopia progression reported on average in 6-month trial assessing MiYOSMART iQ spectacle lenses

HOYA Vision Care announced interim 6-month clinical data from a randomized controlled trial evaluating the safety and efficacy of MiYOSMART iQ spectacle lenses during the 41st Asia-Pacific Academy of Ophthalmology Congress held February 5–8, 2026, in Hong Kong. The study assessed the company’s myopia control lenses, which build on its Defocus Incorporated Multiple Segments (DIMS) Technology with a Triple Enhanced Design (DIMS TED), in children aged 4–12 years with progressive myopia.¹

At 6 months, the lenses showed no myopia progression on average with minimal eye growth. Additionally, the MiYOSMART iQ lenses were twice as effective as MiYOSMART spectacle lenses at controlling axial elongation and myopia progression, according to a news release.¹

“These are the most impressive myopia control results seen so far with DIMS Technology based spectacle lenses,” said Natalia Vlasak, MD, MBA, global head of Medical and Scientific Affairs, HOYA Vision Care, in the release. “The conversation has now moved beyond slowing down myopia progression; with the compelling clinical evidence behind MiYOSMART iQ, we are entering a new era of myopia control – where no myopia progression on average could be reached.”

According to the company, MiYOSMART iQ incorporates 3 design enhancements compared with previous MiYOSMART lenses: a smaller clear central zone with defocus segments positioned closer to the center to activate the near-peripheral retina; higher defocus power intended to provide a stronger myopic defocus signal; and an extended treatment zone with additional defocus segments designed to increase peripheral visual field coverage, including for larger frames.¹

"With childhood myopia on the rise globally, MiYOSMART iQ represents the culmination of over a decade of HOYA innovation and research dedicated to addressing this challenge,” said John Goltermann Lassen, CEO, HOYA, in the release. “With DIMS TED, we’ve developed our most advanced myopia control solution yet – elevating the standard of care in myopic children’s vision, by ushering in a new age in which there is no myopia progression on average. What’s more, myopic children and their families can be assured that MiYOSMART iQ spectacle lenses are crafted with aesthetics in mind and look just like standard SV spectacle lenses. This thoughtful innovation reflects our commitment to protecting children's vision health and to providing Eye Care Professionals with the scientific foundation they need to deliver the highest standard of pediatric care."

MiYOSMART iQ is currently available in major eye hospitals across China, with a broader rollout planned through 2026. The product will be sold alongside existing MiYOSMART spectacle lenses, which the company reported have exceeded 13 million purchases across more than 50 countries since their 2018 launch.¹

In other news

HOYA also recently launched its virtual try-on system HOYA LensPreview, which can be found on the HOYA Hub. The system allows patients to virtually try on lenses including those from the Sensity^® Family, the Mirror Collection, Lumacore™, and polarized lenses.²

“We’re thrilled to introduce HOYA LensPreview as part of our commitment to innovation,” said Samy Lauriette, vice president of Strategic Marketing, North America at HOYA, in a news release.² “This tool enhances the patient experience and helps practices boost second-pair and sun lens sales while eliminating the need for physical samples.”

References

1. HOYA Vision Care presents breakthrough 6-month MiYOSMART iQ clinical evidence at Asia-Pacific Academy of Ophthalmology Congress 2026. News release. HOYA Vision Care. February 8, 2026. Accessed February 9, 2026. https://www.hoyavision.com/about-hoya/hoya-vision-care-news/news/miyosmart-iq--6-month-clinical-evidence--hoya-vision-care-press-release/
2. HOYA Vision Care announces the launch of HOYA LensPreview virtual try-on for photochromic, polarized, and mirror lenses. News release. January 13, 2026. Accessed February 9, 2026. https://www.hoyavision.com/en-us/newsroom/hoya-in-the-news/news-folder/2926-lenspreview-news-release/